These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Risk factors for nosocomial imipenem-resistant Acinetobacter baumannii infections. Baran G; Erbay A; Bodur H; Ongürü P; Akinci E; Balaban N; Cevik MA Int J Infect Dis; 2008 Jan; 12(1):16-21. PubMed ID: 17513154 [TBL] [Abstract][Full Text] [Related]
5. Emergence of carbapenem resistance in Acinetobacter baumannii in the Czech Republic is associated with the spread of multidrug-resistant strains of European clone II. Nemec A; Krízová L; Maixnerová M; Diancourt L; van der Reijden TJ; Brisse S; van den Broek P; Dijkshoorn L J Antimicrob Chemother; 2008 Sep; 62(3):484-9. PubMed ID: 18477708 [TBL] [Abstract][Full Text] [Related]
6. Identification of multidrug- and carbapenem-resistant Acinetobacter baumannii in Canada: results from CANWARD 2007. McCracken M; DeCorby M; Fuller J; Loo V; Hoban DJ; Zhanel GG; Mulvey MR J Antimicrob Chemother; 2009 Sep; 64(3):552-5. PubMed ID: 19578083 [TBL] [Abstract][Full Text] [Related]
7. Early experience with tigecycline for ventilator-associated pneumonia and bacteremia caused by multidrug-resistant Acinetobacter baumannii. Schafer JJ; Goff DA; Stevenson KB; Mangino JE Pharmacotherapy; 2007 Jul; 27(7):980-7. PubMed ID: 17594203 [TBL] [Abstract][Full Text] [Related]
8. Acinetobacter baumannii-associated skin and soft tissue infections: recognizing a broadening spectrum of disease. Guerrero DM; Perez F; Conger NG; Solomkin JS; Adams MD; Rather PN; Bonomo RA Surg Infect (Larchmt); 2010 Feb; 11(1):49-57. PubMed ID: 19788383 [TBL] [Abstract][Full Text] [Related]
9. Rifampicin/imipenem combination in the treatment of carbapenem-resistant Acinetobacter baumannii infections. Saballs M; Pujol M; Tubau F; Peña C; Montero A; Domínguez MA; Gudiol F; Ariza J J Antimicrob Chemother; 2006 Sep; 58(3):697-700. PubMed ID: 16895941 [TBL] [Abstract][Full Text] [Related]
10. Multidrug-resistant Acinetobacter meningitis in neurosurgical patients with intraventricular catheters: assessment of different treatments. Rodríguez Guardado A; Blanco A; Asensi V; Pérez F; Rial JC; Pintado V; Bustillo E; Lantero M; Tenza E; Alvarez M; Maradona JA; Cartón JA J Antimicrob Chemother; 2008 Apr; 61(4):908-13. PubMed ID: 18281693 [TBL] [Abstract][Full Text] [Related]
11. Role of tigecycline in the control of a carbapenem-resistant Acinetobacter baumannii outbreak in an intensive care unit. Jamal W; Salama M; Dehrab N; Al Hashem G; Shahin M; Rotimi VO J Hosp Infect; 2009 Jul; 72(3):234-42. PubMed ID: 19493588 [TBL] [Abstract][Full Text] [Related]
12. Nosocomial multidrug-resistant Acinetobacter baumannii in the neonatal intensive care unit in Gaza City, Palestine. Al Jarousha AM; El Jadba AH; Al Afifi AS; El Qouqa IA Int J Infect Dis; 2009 Sep; 13(5):623-8. PubMed ID: 19144555 [TBL] [Abstract][Full Text] [Related]
13. Emergence of multidrug-resistant isolates of Acinetobacter baumannii. Okpara AU; Maswoswe JJ Am J Hosp Pharm; 1994 Nov; 51(21):2671-5. PubMed ID: 7856578 [TBL] [Abstract][Full Text] [Related]
15. Risk factors and clinical outcomes of multidrug-resistant Acinetobacter baumannii bacteremia at a university hospital in Thailand. Anunnatsiri S; Tonsawan P Southeast Asian J Trop Med Public Health; 2011 May; 42(3):693-703. PubMed ID: 21706949 [TBL] [Abstract][Full Text] [Related]
16. Clonal spread of carbapenem resistant Acinetobacter baumannii in the patients and their environment at BMA Medical College and Vajira Hospital. Phumisantiphong U; Diraphat P; Utrarachkij F; Uaratanawong S; Siripanichgon K J Med Assoc Thai; 2009 Dec; 92 Suppl 7():S173-80. PubMed ID: 20232570 [TBL] [Abstract][Full Text] [Related]
17. Multidrug-resistant Acinetobacter baumannii isolates in pediatric patients of a university hospital in Taiwan. Chang PY; Hsueh PR; Wu PS; Chan PC; Yang TT; Lu CY; Chang LY; Chen JM; Lee PI; Lee CY; Huang LM J Microbiol Immunol Infect; 2007 Oct; 40(5):406-10. PubMed ID: 17932600 [TBL] [Abstract][Full Text] [Related]
18. Acinetobacter baumannii: an emerging multidrug-resistant threat. Gootz TD; Marra A Expert Rev Anti Infect Ther; 2008 Jun; 6(3):309-25. PubMed ID: 18588496 [TBL] [Abstract][Full Text] [Related]
19. Clinical outcomes of patients infected with carbapenem-resistant Acinetobacter baumannii treated with single or combination antibiotic therapy. Santimaleeworagun W; Wongpoowarak P; Chayakul P; Pattharachayakul S; Tansakul P; Garey KW J Med Assoc Thai; 2011 Jul; 94(7):863-70. PubMed ID: 21774295 [TBL] [Abstract][Full Text] [Related]
20. [Acinetobacter baumannii: an important pathogen with multidrug resistance in newborns]. Celik IH; Demirel G; Tatar Aksoy H; Saygan S; Canpolat FE; Uras N; Oğuz SS; Erdeve O; Dilmen U Mikrobiyol Bul; 2011 Oct; 45(4):716-22. PubMed ID: 22090302 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]